3Kenneth A, Jerry J. Shining some light on the development of pulmonary edema. Critical Care Medicine, 1999, 27(9) : 2046-2047.
4Steven M, Cohen DO, Faizi A, et al. Attenuation of acute lung injury caused by Hing-limb ischemia-reperfusion injury by butyrolactone anti-inflammatory agent FL1003.The Journal of Trauma, 1997, 43(2): 247-252.
5Murphy PC,, Myers DS, Davies 1KI, et al .The antioxidant potential of propofol. British Journal of Anaesthesia, 1992,68(6) :613-618.
6Kvam C,Granese D,Flaibani A,et al. Hyahtronan can be protect from freeradical depolymerisation by 2,6- diisopropylphend, a novel radical scavenger. Biochemical and Biophysical Research Communication, 1993 , 193 (3) :927-933.
7Chang KSK, Davis RF. Propofol prnduces endothelin independent vasokilation and may cat as a Ca^2+ channel blocker. Anesthesia and Analgesia, 1993,76( 1 ) : 24-32.
8Foster A, Zeller W, Pfannkuche HJ. Effoet of thiopental, saffan, and propofol anesthesia on cardiovascular parameters and branchial smooth muscle in the rhesus monkey. Laboratory Animal Science, 1996, 46(3): 327-334.
9Rick SC, Wu KC, Wu CW, et al. Coparative effects of thiopental and prop(ffol on total respiratory system resistance after tracheal intubation. Anesthesia and Analgesia, 1997, 84:S597.
10Brown RH, Wagner EM. Mechanisms of bronchoprotection by anesthetic induction agents: propofol versus ketamine. Anesthesiology, 1999,90 ( 3 ) : 822-828.
